Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A288904
Thu, 07.11.2024
CompuGroup Medical SE & Co. KGaA
CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues
Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 283.4 million in the third quarter of the 2024 financial year, slightly (-1 percent) below the previous year's level (PY: EUR 285.7 million), w [ … ]
Wed, 31.07.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
Koblenz. CompuGroup Medical announced today that the Administrative Board appoints the company founder’s son, Prof. (apl.) Dr. med. Daniel Gotthardt, as CEO of CGM effective as of September 1, 2024. The current CEO Michael Rauch will leave the company in the best mutual agreement to [ … ]
Wed, 31.07.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business
Koblenz - CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, has gained another experienced healthcare expert. On August 1, Ulf Hönick will take over the management of CGM Lauer. Over the past few years, Ulf Hönick has supporte [ … ]
Wed, 17.07.2024
CompuGroup Medical SE & Co. KGaA
100 million e-prescriptions issued in CGM's German practice software systems
Koblenz - 100 million e-prescriptions have been issued in the German ambulatory information systems supplied by CompuGroup Medical (CGM). CGM is thus the first practice software provider to exceed this mark. More than 32 percent of all e-prescriptions generated in German [ … ]
Mon, 15.07.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024
Against the backdrop of the ad-hoc announcement on July 9, 2024, the general partner of CompuGroup Medical SE & Co. KGaA (ISIN: DE000A288904 | WKN: A28890) (“CGM”) has decided to prepone the publication of the financial results for the first half of th [ … ]
Mon, 01.07.2024
CompuGroup Medical SE & Co. KGaA
CGM receives C5 attestation according to BSI Criteria
Koblenz - CompuGroup Medical (CGM) has received C5 attestation (Type 1) for cloud services in Germany in accordance with the criteria of the German Federal Office for Information Security (BSI). Cloud products of CGM have been attested compliance with C5 criteria retroactively as of May 31, 2 [ … ]
Tue, 25.06.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
Fast growing, fully web-based ambulatory information system with added value for doctors due to great user experience
Fast tracking the evolving customer needs regarding interoperability and data sharing
Foundation for further expansion in [ … ]
Tue, 25.06.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
Fast growing, fully web-based ambulatory information system with added value for doctors due to great user experience
Fast tracking the evolving customer needs regarding interoperability and data sharing
Foundation for further expansion in [ … ]
Tue, 18.06.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical acquires AmbulApps
Koblenz - CompuGroup Medical acquires AmbulApps GmbH, a specialist in digital anamnesis tools. Founded in Neuss in 2015, the company organizes, digitizes and structures the collection of data from and about patients. CompuGroup Medical will integrate AmbulApps' applications into its portfolio of solutions an [ … ]
Wed, 22.05.2024
CompuGroup Medical SE & Co. KGaA
CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
Acts of the governing boards formally approved
Dividend proposal of EUR 1.00 confirmed
High approval rates for capital measures
Focus on data-based solutions and artificial intelligence
Koblenz - The shareholders of CompuGroup Medical SE & Co. [ … ]